Russia Will Apply for Sputnik V Vaccine Approval in the EU

The head of the Russian Direct Investment Fund said that experts will confirm vaccine the effectiveness In February, Russia will submit an official application for approving its Sputnik V coronavirus vaccine in the EU, the head of the Russian Direct Investment Fund said. In the near future, an expert assessment to confirm the Russian vaccine’s high effectiveness will be published, Kirill Dmitriev said in an interview with Reuters. According to him, Sputnik V will be produced in seven countries. He added that this month, regulators in nine countries are expected to approve the vaccine for domestic use. It has already been approved in Argentina, Belarus, Serbia and some other countries.